- Served as the Director of the Health Industry Department of China Great Wall Asset Management Co., Ltd., Managing Director of Guoxin Qidi Fund Management Co., Ltd., Managing Partner of Yinglian Health Industry Fund Management, and General Manager of Wuxi Guolian Capital

- Currently serves as the President of Wuxi Innovation Investment Group Co., Ltd. and Chairman of V-Capital

- Possesses extensive experience in investment banking and investment management. Recognized as the TOP 100 Young Leaders in the Investment Industry by FOFWEEKLY in 2025, the Top 20 Life Science Industry Investors in China by 36Kr in 2025, and an Outstanding Investor of the Year by Chinese Venture in 2025

- Holds a bachelor's and master's degree in Biological Sciences from Tsinghua University and a Ph.D. in Public Health from Johns Hopkins University

- Previously served in well-known institutions such as Changsheng Fund, Dacheng Fund, and Everbright Securities, overseeing investments, research and derivative products

- An executive at China Everbright Investment Company，primarily responsible for primary market investment

- Formerly served as a member of the Guiyang Municipal Committee and Deputy Mayor

- Extensive experience in investment markets and government administration

- EMBA from the China Europe International Business School (CEIBS)

- CFA, Tsinghua -MIT MBA

- Worked at RM of Standard Chartered Bank, VP of CITIC fund, CIO of Fortis Haitong Asset Management Co., CEO and RO of BNP Paibas-Haitong Asset Management (Hongkong) Company, Vice General Manager of Fullgoal Asset Management, RO of Fullgoal HongKong Asset Management Co.,

- Rich experience in customer service, marketing, institutional service, cross-border business and related management and operation in the asset management industry

- China-FOF·China Outstanding Female Direct Investment Fund Investors 2020, Chinese Venture·Beauty With Power 2020-2021

- Graduated from Fudan University and University of Reading

- Has served as a member of Investment Committee, vice president of Corporate Finance Division of Haitong Securities, tax and business consultant of Deloitte

- Over ten years’ experience in investment banking, M&A investment; the amount of capital Roger manages has added up to $ 0.7 billion, presided over numerous famous Reorganization Projects

- Extensive background in privatization of overseas companies, overseas M& A, designing structure of M& A deals, tax planning etc..

- Previously worked at Deloitte Touche Tohmatsu Certified Public Accountants LLP and Noah Holdings Limited, specializing in financial auditing, internal control auditing, risk review and disposal of financial products, and construction of risk control architecture systems. Accumulated experience in reviewing over 600 financial products, with a profound understanding and rich practical experience in risk management

- Possesses extensive experience in equity investment and risk management across primary and secondary markets

- Certified Public Accountant of China

- Dual Bachelor's degree in Finance and Law from Shanghai Jiao Tong University

- EMBA from the China Europe International Business School (CEIBS)

- Vice President of the Shenzhen Venture Capital Association

- Founded Shenzhen Guanyu Venture Capital Co. and Co-Power Venture Capital Co., Ltd

- Previously served as the General Manager of United Securities Sales Department, and as a senior executive at Lenovo's Winsun Communications Company

- Successfully spearheaded investments in projects such as 7Road, HeRun Media Group, Suntak Technology, and Temobi

- Graduated from Guanghua School of Management of Peking University

- Over 20 years of experience in the pharmaceutical industry operations, investment and financial industry, has a wealth of practical experience in M&A, venture capital and industry consolidation

- The total amount of capital Peter manages has exceeded $ 0.7 billion

- Former President of Sanjiu Enterprise group; had participated in the reorganization of several pharmaceutical enterprises

- Former Chairman of three public companies: Jianmin Pharmaceutical (600976), KPC Pharmaceuticals Inc. (600422), Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)

- Expertized in financial product innovation, has served  in Fortune SG Fund Management and Hua An Funds

- Has dominated the early research and development in the domestic precious metals ETF fund's first exchange traded crude oil investment fund's first exchange traded currency fund, the first quantitative asset allocation fund

- Has been deeply involved in mergers and acquisitions of listed companies, cross-border investment arbitrage, domestic debt financing and other business process design and product development

- Former senior product manager of Fortune SG Fund Management Co., Ltd ; product supervisor of HuaAn Funds

- DBA from Shanghai Advanced Institute of Finance-Arizona State University, Tsinghua MBA, Bachelor of Engineering from University of Science and Technology Beijing

- Former general manager in trust sector of Customer Department of E FUND, vice president of CITIC Securities Asset Management business

-Over 10 years of business experience in the capital market in top institutional bodies, specializing in industrial operation and empowerment, with a cumulative fund size of over 0.7 billion under management

- MBA degree of CEIBS,Bachelor of NUAA

- Over 20 years’ experience in GE, Schneider Electric and other Fortune Global 500 as Master Black Belt,Director of Global Excellence Operations and other positions engaging in process optimization, operational excellence and enterprise management

- Worked as a partner in Everpine Capital, responsible for post-investment management and fund project landing